Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer (COMREC)

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Enrolling

Conditions: Rectal Neoplasms

Treatments: Other: Registry study, no specific intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05871762

2022-PUMCH-C-027

Details and patient eligibility

About

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Enrollment: 3,705 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• pathologically confirmed rectal adenocarcinoma
• located within 12cm below the anal verge

Exclusion criteria

• diagnosed with distant metastasis
• multiple primary colorectal cancers
• history of previous malignant tumors
• Pregnant or lactating women